Details of issuance or disposal
Monthly exercise status of the 11th Series Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment and exercise suspension provisions)
Shares delivered during the month: — shares. New shares: — shares; treasury shares transferred: — shares
The lower thin line represents the existing number of shares to which these shares will be added.
Exercise ratio during the month: —%; exercise ratio subject to exercise restrictions: —%
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of the 11th Series Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment and exercise suspension provisions) |
| Number of shares to be issued or disposed of | Shares delivered during the month: — shares. New shares: — shares; treasury shares transferred: — shares |
| Intended allottee | EVO FUND (issued on 12 February 2026) |
| Dilution Rate | Exercise ratio during the month: —%; exercise ratio subject to exercise restrictions: —% |
| Total number of issued shares | 17,091,892 shares (as of the end of the month preceding the reporting month, including 229,999 treasury shares) → Not disclosed |
| Exercise price | ¥195 (exercise price during the month). Details of the adjustment provisions and the adjustment floor: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 104,596 units. Unexercised balance at the end of the month preceding the reporting month and at month-end: 83,100 units (8,310,000 shares) |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | 12 February 2026: Issuance of the 11th Series of Stock Acquisition Rights allocated to EVO FUND. Amount: Not disclosed |
Items this document does not state (19)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company has not stated a reason. The filing reports the monthly exercise status for October 2026.